Cencora (BSP:C1CO34) Change In Payables And Accrued Expense : R$17,551 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Cencora Change In Payables And Accrued Expense?

Cencora's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was R$-1,504 Mil. It means Cencora's Accounts Payable & Accrued Expense declined by R$1,504 Mil from Dec. 2024 to Mar. 2025 .

Cencora's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2024 was R$27,202 Mil. It means Cencora's Accounts Payable & Accrued Expense increased by R$27,202 Mil from Sep. 2023 to Sep. 2024 .

Cencora Change In Payables And Accrued Expense Historical Data

The historical data trend for Cencora's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Change In Payables And Accrued Expense Chart

Cencora Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

20,383.59

11,841.46

13,284.20

29,426.83

27,202.28

Cencora Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-6,700.21	19,967.63	5,453.26	-6,366.32	-1,503.79

Cencora Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$17,551 Mil.

Cencora Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cencora's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (BSP:C1CO34) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

COR:USA COR:Mexico 1COR:Italy 0HF3:UK ABG:Germany ABG:Germany ABC:Austria

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora Headlines

No Headlines